Sumatriptan Succinate Tablet
Product Images NDC 55111-291

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sumatriptan Succinate (NDC 55111-291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Carton1 (Carton1)

Carton1 (Carton1)
FDA Label Image

Carton2 (Carton2)

Carton2 (Carton2)
FDA Label Image

Carton3 (Carton3)

Carton3 (Carton3)
FDA Label Image

Container1 (Container1)

Container1 (Container1)
FDA Label Image

Container2 (Container2)

Container2 (Container2)
FDA Label Image

Container3 (Container3)

Container3 (Container3)
FDA Label Image

Figure1

Figure1
This is a table showing the estimated probability of response in three levels: 100%, 70%, and 0%.*
FDA Label Image

Figure2

Figure2
This appears to be a chart showing the estimated probability of requiring additional treatment or rescue over time after an initial dose, represented as a percentage. However, there is not enough information to provide a more detailed description.*
FDA Label Image

Structure (Structure)

Structure (Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.